›› 2020, Vol. 40 ›› Issue (8): 762-766.
• Summary • Previous Articles Next Articles
Received:
2019-07-23
Revised:
2019-08-28
Online:
2020-08-29
Published:
2020-08-28
Contact:
Jingyun N/AWang
E-mail:jlccjingyun@sina.com
CLC Number:
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
1. Buser, D., K. Dula, U. Belser, H.P. HirtH. Berthold. Localized ridge augmentation using guided bone regeneration. 1. Surgical procedure in the maxilla. Int J Periodontics Restorative Dent. 1993; 13: 29-45.2. Nyman, S., J. Lindhe, T. KarringH. Rylander. New attachment following surgical treatment of human periodontal disease. Journal of Clinical Periodontology. 1982; 9: 290-296.3. Arash, K., M. GolnazB. Hossein. Clinical importance of recipient site characteristics for vertical ridge augmentation: a systematic review of literature and proposal of a classification. J Oral Implantol. 2013; 39: 386.4. Liu, J.D.G. Kerns. Mechanisms of Guided Bone Regeneration: A Review. 2014: 5. Rakhmatia, Y.D., Y. Ayukawa, A. FuruhashiK. Koyano. Current barrier membranes: Titanium mesh and other membranes for guided bone regeneration in dental applications. J Prosthodont Res. 2013; 57: 3-14.6. Dimitriou, R., G.I. Mataliotakis, G.M. CaloriP.V. Giannoudis. The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence. Bmc Medicine. 2012; 10: 81.7. Selvig, K.A., B.G. Kersten, A.D. Chamberlain, U.M. Wikesj?R.E. Nilvéus. Regenerative surgery of intrabony periodontal defects using ePTFE barrier membranes: scanning electron microscopic evaluation of retrieved membranes versus clinical healing. Journal of Periodontology. 1992; 63: 974-978.8. Lee, S.W.S.G. Kim. Membranes for the Guided Bone Regeneration. Maxillofacial Plastic & Reconstructive Surgery. 2014; 36: 239-246.9. El-Jawhari, J.J., K. Moisley, E. JonesP.V. Giannoudis. A crosslinked collagen membrane versus a non-crosslinked bilayer collagen membrane for supporting osteogenic functions of human bone marrow-multipotent stromal cells. Eur Cell Mater. 2019; 37: 292-309.10. Mathew, A., et al. Antimicrobial and Immunomodulatory Surface-Functionalized Electrospun Membranes for Bone Regeneration. Advanced Healthcare Materials. 2017; 18: 133.11. Padalhin, A.R., T.B.L. Nguyen, K.M. YoungL. Byong-Taek. Evaluation of the cytocompatibility hemocompatibility in vivo bone tissue regenerating capability of different PCL blends. Journal of Biomaterials Science Polymer Edition. 2014; 25: 487-503.12. Cao, C., et al. Preparation and preliminary in vitro evaluation of a bFGF-releasing heparin-conjugated poly(ε-caprolactone) membrane for guided bone regeneration. Journal of Biomaterials Science Polymer Edition. 2015; 26: 600-616.13. Barrientos, S., O. Stojadinovic, Ms, H. BremM. Tomic-Canic. Growth factors and cytokines in wound healing. Wound Repair & Regeneration. 2010; 16: 585-601.14. KoriaPiyush. Delivery of Growth Factors for Tissue Regeneration and Wound Healing. Biodrugs. 2012; 26: 163-175.15. Martino, M.l.M., P.S. Briquez, K. MaruyamaJ.A. Hubbell. Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Advanced Drug Delivery Reviews. 2015; 94: 41-52.16. Lissenberg-Thunnissen, S.N., D.J.J.d. Gorter, C.F.M. SierI.B. Schipper. Use and efficacy of bone morphogenetic proteins in fracture healing. International Orthopaedics. 2011; 35: 1271-1280.17. Keramaris, N.C., G.M. Calori, V.S. Nikolaou, E.H. SchemitschP.V. Giannoudis. Fracture vascularity and bone healing: A systematic review of the role of VEGF. Injury-international Journal of the Care of the Injured. 2008; 39: S45-S57.18. Hollinger, J.O., C.E. Hart, S.N. Hirsch, S. LynchG.E. Friedlaender. Recombinant human platelet-derived growth factor: biology and clinical applications. Journal of Bone & Joint Surgery American Volume. 2008; 90 Suppl 1: 48-54.19. Du, X., Y. Xie, C.J. XianL. Chen. Role of FGFs/FGFRs in skeletal development and bone regeneration. Journal of Cellular Physiology. 2012; 227: 3731-3743.20. Kempen, D.H., et al. Growth factor interactions in bone regeneration. Tissue Eng Part B Rev. 2010; 16: 551-66.21. Cicciù, M., A. Scott, D. Cicciù, R. TandonC. Maiorana. Recombinant Human Bone Morphogenetic Protein-2 Promote and Stabilize Hard and Soft Tissue Healing for Large Mandibular New Bone Reconstruction Defects. Journal of Craniofacial Surgery. 2014; 25: 860-862.22. Zétola, A., F.M. Ferreira, R. LarsonJ.A. Shibli. Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection. Oral & Maxillofacial Surgery. 2011; 15: 169-174.23. El Bialy, I., W. JiskootM. Reza Nejadnik. Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration. Pharmaceutical Research. 2017; 34: 1152-1170.24. Claes, L., S. RecknagelA. Ignatius. Fracture healing under healthy and inflammatory conditions. Nature Reviews Rheumatology. 2012; 8: 133-143.25. Deckers, M.M.L., et al. Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. Endocrinology. 2002; 143: 1545-1553.26. Tsuji, K., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nature Genetics. 2006; 38: 1424-1429.27. Gerstenfeld, L.C., D.M. Cullinane, G.L. Barnes, D.T. GravesT.A. Einhorn. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. Journal of Cellular Biochemistry. 2003; 88: 873–884.28. Crockett, J.C., M.J. Rogers, F.P. Coxon, L.J. HockingM.H. Helfrich. Bone remodelling at a glance. J Cell Sci. 2011; 124: 991-8.29. J.M., G., O. R.C., B.-V. J.C., S. M.C.T. R. Bone morphogenetic proteins: from structure to clinical use. Brazilian Journal of Medical & Biological Research. 2005; 38: 1463-1473.30. Seeherman, H.J.M. Wozney. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine & Growth Factor Reviews. 2005; 16: 329-345.31. Cross, M.J., J. Dixelius, T. MatsumotoL. Claesson-Welsh. VEGF-receptor signal transduction. Trends in Biochemical Sciences. 2003; 28: 488-494.32. Orlandini, M., et al. Vascular Endothelial Growth Factor-D Activates VEGFR-3 Expressed in Osteoblasts Inducing Their Differentiation *. Journal of Biological Chemistry. 2006; 281: 17961.33. Street, J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A. 2002; 99: 9656-9661.34. Emad, B., et al. Vascular endothelial growth factor augments the healing of demineralized bone matrix grafts. International Journal of Surgery. 2006; 4: 160-166.35. Andrae, J., R. GalliniC. Betsholtz. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008; 22: 1276.36. Kaigler, D., et al. Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opinion on Biological Therapy. 2011; 11: 375.37. Shah, P., L. KepplerJ. Rutkowski. A review of Platelet Derived Growth Factor playing pivotal role in bone regeneration. J Oral Implantol. 2014; 40: 330-340.38. Teven, C.M., E.M. Farina, J. RivasR.R. Reid. Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis. 2014; 1: 199-213.39. Yun, Y.R., et al. Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration. Journal of Tissue Engineering,1,1(). 2010; 2010: 218142.40. OrnitzD. M. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes & Development. 2002; 16: 1446-65.41. Nakamura, Y., et al. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone. 2005; 36: 399-407.42. Kimoto, T., et al. Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria-- An Application of a New Drug Delivery System. Journal of Dental Research. 1998; 77: 1965.43. Lee, K., E.A. SilvaD.J. Mooney. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. Journal of the Royal Society Interface. 2011; 8: 153.44. Masako, F.-K., et al. Comparison of Two Porcine Collagen Membranes Combined with rhBMP-2 and rhBMP-9 on Osteoblast Behavior In Vitro. The International Journal of Oral & Maxillofacial Implants. 45. Hong, K.S., et al. Bone regeneration by bioactive hybrid membrane containing FGF2 within rat calvarium. Journal of Biomedical Materials Research Part A. 2010; 94A: 1187-1194.46. Du, M., et al. Acellular dermal matrix loading with bFGF achieves similar acceleration of bone regeneration to BMP-2 via differential effects on recruitment, proliferation and sustained osteodifferentiation of mesenchymal stem cells. Materials Science & Engineering C. 2017; 70: 62-70.47. Mozgan, E.-M., et al. Release kinetics and mitogenic capacity of collagen barrier membranes supplemented with secretome of activated platelets - the in vitro response of fibroblasts of the periodontal ligament and the gingiva. Bmc Oral Health. 2017; 17: 66.48. Lee, S.J., et al. Molded porous poly (L-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release. Journal of Biomedical Materials Research Part A. 2015; 55: 295-303.49. Ming-Hua, H., et al. PDGF-metronidazole-encapsulated nanofibrous functional layers on collagen membrane promote alveolar ridge regeneration. International Journal of Nanomedicine. 2017; Volume 12: 5525-5535.50. Kim, H.Y., J.H. Park, J.H. Byun, J.H. LeeS.H. Oh. BMP-2-Immobilized Porous Matrix with Leaf-Stacked Structure as a Bioactive GBR Membrane. ACS Appl Mater Interfaces. 2018; 10: 30115-30124. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||